Rapid and massive virus-specific plasmablast responses during acute: Dengue virus infection in humans

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 2911-2918

  Wrammert, Jens ^a   Onlamoon, Nattawat ^b,d   Akondy, Rama S ^a   Perng, Guey C ^a   Polsrila, Korakot ^b   Chandele, Anmol ^a   Kwissa, Marcin ^a   Pulendran, Bali ^a   Wilson, Patrick C ^c   Wittawatmongkol, Orasri ^b   Yoksan, Sutee ^d   Angkasekwinai, Nasikarn ^e   Pattanapanyasat, Kovit ^b,d   Chokephaibulkit, Kulkanya ^b   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF CHICAGO   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ACUTE DISEASE; ACUTE PHASE RESPONSE; ADULT; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CELL EXPANSION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DENGUE; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PLASMA CELL; PRIORITY JOURNAL; SCHOOL CHILD; SECRETORY CELL; VIRUS INDUCTION; VIRUS INFECTIVITY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNITY, HUMORAL; INFANT; MALE; MIDDLE AGED; PLASMA CELLS; SPECIES SPECIFICITY; YOUNG ADULT;

DENGUE VIRUS;

EID: 84857963464     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06075-11     Document Type: Article

References (36)

1. Akondy RS, et al. 2009. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J. Immunol. 183:7919 -7930.
2. Beltramello M, et al. 2010. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8:271-283.
3. Bernasconi NL, Traggiai E, Lanzavecchia A. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199 -2202.
4. Bethell DB, et al. 1998. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177:778 -782.
5. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. 1967. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 61:500 -510.
6. Blackley S, et al. 2007. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J. Virol. 81:13325-13334.
7. Boonpucknavig S, Lohachitranond C, Nimmanitya S. 1979. The pattern and nature of the lymphocyte population response in dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 28:885- 889.
8. Burke DS, Nisalak A, Johnson DE, Scott RM. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:172-180.
9. Crotty S, Aubert RD, Glidewell J, Ahmed R. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
10. Dejnirattisai W, et al. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745-748.
11. Dung NT, et al. 2010. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J. Immunol. 184:7281-7287.
12. Green S, et al. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:755-762.
13. Green S, et al. 1999. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59:329 -334.
14. Halstead SB, O'Rourke EJ. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739 -741.
15. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P. 1996. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol. Immunol. 40:569 -573.
16. Hober D, et al. 1993. Serum levels of tumor necrosis factor-alpha (TNFalpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengueinfected patients. Am. J. Trop. Med. Hyg. 48:324 -331.
17. Huang KJ, et al. 2006. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol. 176:2825-2832.
18. Innis BL, et al. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am. J. Trop. Med. Hyg. 40:418-427.
19. Jampangern W, et al. 2007. Characterization of atypical lymphocytes and immunophenotypes of lymphocytes in patients with dengue virus infection. Asian Pac. J. Allergy Immunol. 25:27-36.
20. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989. Antibodydependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444-451.
21. Klungthong C, Zhang C, Mammen MP, Jr, Ubol S, Holmes EC. 2004. The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 329:168 -179.
22. Kurane I, et al. 1994. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 9:59-64.
23. Mathew A, Rothman AL. 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225:300-313.
24. Miller JD, et al. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28:710 -722.
25. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. 2001. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 30:229 -233.
26. Nimmerjahn F, Ravetch JV. 2010. Antibody-mediated modulation of immune responses. Immunol. Rev. 236:265-275.
27. Onlamoon N, et al. 2010. Dengue virus-induced hemorrhage in a nonhuman primate model. Blood 115:1823-1834.
28. Piyaratn P. 1961. Pathology of Thailand epidemic hemorrhagic fever. Am. J. Trop. Med. Hyg. 10:767-772.
29. Sangkawibha N, et al. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120:653- 669.
30. Simmons CP, et al. 2007. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 195:1097-1107.
31. Suwannasaen D, Romphruk A, Leelayuwat C, Lertmemongkolchai G. 2010. Bystander T cells in human immune responses to dengue antigens. BMC Immunol. 11:47.
32. Thein S, et al. 1997. Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56:566 -572.
33. Tough DF, Borrow P, Sprent J. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950.
34. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. World Health Organization, Geneva, Switzerland.
35. Wrammert J, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453:667- 671.
36. Yenchitsomanus PT, et al. 1996. Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR). Southeast Asian J. Trop. Med. Public Health 27:228 -236.